Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

IDL Diagnostics

0.38 SEK

+9.71 %

Less than 1K followers

IDLDX

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for IDL Diagnostics

2019202020212022202320242025
Revenue0.40.112.037.043.057.453.1
growth-%-81.0 %14,181.0 %208.4 %16.4 %33.5 %-7.5 %
EBITDA-20.7-24.1-50.6-59.3-59.8-43.4-8.4
EBIT-20.7-24.1-50.6-59.3-59.8-43.4-12.0
Profit before taxes-20.7-24.1-50.6-59.3-59.3-42.5-12.2
Net income-20.7-24.1-50.6-59.3-59.3-42.5-12.2
EPS-0.52-0.31-0.53-0.28-0.26-0.18-0.05
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-4,680.8 %-28,633.3 %-421.6 %-160.3 %-138.9 %-75.6 %-15.7 %
EBIT-%-4,680.8 %-28,633.3 %-421.6 %-160.3 %-138.9 %-75.6 %-22.6 %
ROE-25.8 %-42.8 %-23.3 %-26.6 %-36.2 %-35.0 %-8.2 %
ROI-22.7 %-39.8 %-22.2 %-25.1 %-33.9 %-31.6 %-6.9 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.